Wolfram Syndrome: A Series of 4 Cases
Abstract Wolfram Syndrome (WS), also known as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), is a rare neurodegenerative disorder [1, 2]. This condition features symptoms that typically appear progressively from childhood through adulthood [3, 4, 5]. Diagnosis is based on specific clinical criteria and confirmed by genetic testing for mutations in the WFS1 gene [6, 7]. Insulin therapy remains the mainstay treatment for diabetes mellitus, but incretin analogs may provide benefit if initiated early [8, 9]. Prognosis is generally poor, with a mean life expectancy of 39 years, often due to central respiratory complications [3, 10]. Gene therapyiscurrentlyexperimental but promising [11].
Authors
- Hinde Iraqi (ORCID: https://orcid.org/0000-0002-4130-6490)
- Kaoutar Rifai
- M. Chaouche
- M.H. Gharbi
- K. Gorgi
Institutions
- Mohamed I University (MA)
- Hôpital Ibn Sina-Rabat (MA)
- Ibn Sina Hospital (KW)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-12-27
- DOI
- https://doi.org/10.5281/zenodo.18302898
- Primary Topic
- Endoplasmic Reticulum Stress and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00